4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum

C57H35N5OPtS-2 — CID 154594904

IUPAC4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum
SMILES[2H]C([2H])([2H])[n+]1[c-]n(-c2[c-]c(Oc3[c-]c(-c4nccc5sccc45)ccc3)ccc2)c2cccc(-c3c(-n4c5ccccc5c5ccccc54)cccc3-n3c4ccccc4c4ccccc43)c21.[Pt]
InChIInChI=1S/C57H35N5OS.Pt/c1-59-36-60(38-15-11-17-40(35-38)63-39-16-10-14-37(34-39)56-45-31-33-64-54(45)30-32-58-56)53-29-12-22-46(57(53)59)55-51(61-47-23-6-2-18-41(47)42-19-3-7-24-48(42)61)27-13-28-52(55)62-49-25-8-4-20-43(49)44-21-5-9-26-50(44)62;/h2-33H,1H3;/q-2;/i1D3;
InChIKeyKTIKSDLCLPTTPS-NIIDSAIPSA-N
MW1036.10 g/mol
LogP13.78
Rot. Bonds8

About 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum

4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum (PubChem CID 154594904) has the molecular formula C57H35N5OPtS-2 and a molecular weight of 1036.10 g/mol. Its IUPAC name is 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum.

Molecular Properties

Compound Name4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum
PubChem CID154594904
Molecular FormulaC57H35N5OPtS-2
Molecular Weight1036.10 g/mol
Exact Mass1035.24
IUPAC Name4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum
SMILES[2H]C([2H])([2H])[n+]1[c-]n(-c2[c-]c(Oc3[c-]c(-c4nccc5sccc45)ccc3)ccc2)c2cccc(-c3c(-n4c5ccccc5c5ccccc54)cccc3-n3c4ccccc4c4ccccc43)c21.[Pt]
InChIInChI=1S/C57H35N5OS.Pt/c1-59-36-60(38-15-11-17-40(35-38)63-39-16-10-14-37(34-39)56-45-31-33-64-54(45)30-32-58-56)53-29-12-22-46(57(53)59)55-51(61-47-23-6-2-18-41(47)42-19-3-7-24-48(42)61)27-13-28-52(55)62-49-25-8-4-20-43(49)44-21-5-9-26-50(44)62;/h2-33H,1H3;/q-2;/i1D3;
InChIKeyKTIKSDLCLPTTPS-NIIDSAIPSA-N
XLogP13.78
TPSA40.79 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms65
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001036.10
LogP ≤ 513.78
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum?
The IUPAC name of 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum (CID 154594904) is 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum.
What is the SMILES notation for 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum?
The canonical SMILES for 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum is [2H]C([2H])([2H])[n+]1[c-]n(-c2[c-]c(Oc3[c-]c(-c4nccc5sccc45)ccc3)ccc2)c2cccc(-c3c(-n4c5ccccc5c5ccccc54)cccc3-n3c4ccccc4c4ccccc43)c21.[Pt].
What is the InChIKey of 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum?
The InChIKey is KTIKSDLCLPTTPS-NIIDSAIPSA-N. The full InChI is InChI=1S/C57H35N5OS.Pt/c1-59-36-60(38-15-11-17-40(35-38)63-39-16-10-14-37(34-39)56-45-31-33-64-54(45)30-32-58-56)53-29-12-22-46(57(53)59)55-51(61-47-23-6-2-18-41(47)42-19-3-7-24-48(42)61)27-13-28-52(55)62-49-25-8-4-20-43(49)44-21-5-9-26-50(44)62;/h2-33H,1H3;/q-2;/i1D3;.
What are the key properties of 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum?
4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum has a molecular weight of 1036.10 g/mol, XLogP of 13.78, 8 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[3-[3-[4-[2,6-di(carbazol-9-yl)phenyl]-3-(trideuteriomethyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]thieno[3,2-c]pyridine;platinum is sourced from PubChem (CID 154594904), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).